REFERENCES
- Steinberg M. H. Modulation of the phenotypic diversity of sickle cell anemia. hemoglobin 1996; 20(1)01–19
- Milner P. F., Kraus A. P., Sebes J. I., Sleeper L. A., Dukes K. A., Embury S. H., Bellevue R., Koshy M., Moohr J. W., Smith J. Sickle cell disease as a cause of osteonecrosis of the femoral head. New Engl. J. Med. 1991; 325: 1476–1481
- Ballas S. K., Talacki C. A., Rao V. M., Steiner R. M. The prevalence of avascular necrosis in sickle cell anemia: correlation with a-thalassemia. Hemoglobin 1989; 13(7&8)649–655
- Andrade F. L., Annichino-Bizzacchi J. M., Saad S. T.O., Costa F. F., Arruda V. R. Prothrombin mutant, factor V leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil. Am. J. Hematol 1998; 59: 46–50
- Cumming A. M., Olujohungbe A., Keeney S., Singh H., Hay C. R.M., Serjeant G. R. The methylenetetrahydrofolate reductase gene C677T polymorphism in patients with homozygous sickle cell disease and stroke. Br. J. Haematol 1999; 107: 569–571
- Driscoll M. C., Prauner R. 5,10-methylenetetrhaydrofolate reductase C677T mutation and stroke in sickle cell. Blood 1997; 90: 2796
- Zimmerman S. A., Heumayer S., Ware R. E. Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease. Blood 1997; 90: 2837
- Kutlar F., Holley L., McKie V. C., McKie K. M., Woods K. F., Kutlar A. Frequency of a common thermolabile MTHFR (5,10-methylene tetrahydrofolate reductase) mutant among patients with sickle cell disease. Blood 1997; 90: 2815
- Frosst P., Blom H. J., Milos R., Goyette P., Sheppard C. A., Matthews R. G., Boers G. J.H., den Heijer M., Kluijtmans L. A.J., van den Heuvel L. P., Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 1995; 10: 111–113
- Girelli D., Friso S., Travetti E., Olivieri O., Russo C., Pessotto R., Faccine G., Pignatti P. F., Mazzucco A., Corrocher R. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Blood 1998; 91 (11): 4158–4163
- Kluijtmans L. A., van den Heuvel L. P.W.J., Boers G. H.J., Frosst P., Stevens E. M.J., van Oost B. A., den Heijer M., Trijbels F. J.M., Rozen R., Blom H. J. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am. J. Hum. Genet. 1996; 58: 35–41
- Engbersen A. M.T., Franken D. G., Boers G. H.J., Stevens E. M.B., Trijbels F. J.M., Blom H. J. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am. J. Hum. Genet 1995; 56: 142–150
- Poncz M., Solowiejczyk D., Harpel B., Mory Y., Schwartz E., Surrey S. Construction of human gene libraries from small amounts of peripheral blood: analysis of b-like globin genes. Hemoglobin 1982; 6(1)27–36
- Adekile A. D., Kutlar F., Haider M. Z., Gupta R., Yacoub F., Kutlar A. Frequency of the 677 C→T mutation of the methylenetetrahydrofolate reductase gene among Kuwaiti sickle cell disease patients: association with Osteonecrosis. Am. J. Hematol, 2001, in press